Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 183

1.

Video NeuroImages: Head titubation in anti-mGluR1 autoantibody-associated cerebellitis.

Pedroso JL, Dutra LA, Espay AJ, Höftberger R, Barsottini OGP.

Neurology. 2018 Apr 17;90(16):746-747. doi: 10.1212/WNL.0000000000005338. No abstract available.

PMID:
29661893
2.

Disease modification in Parkinson's Disease: Current approaches, challenges, and future considerations.

Lang AE, Espay AJ.

Mov Disord. 2018 Apr 11. doi: 10.1002/mds.27360. [Epub ahead of print] Review.

PMID:
29644751
3.

Small intestinal bacterial overgrowth in Parkinson's disease: Tribulations of a trial.

Vizcarra JA, Wilson-Perez HE, Fasano A, Espay AJ.

Parkinsonism Relat Disord. 2018 Apr 4. pii: S1353-8020(18)30148-2. doi: 10.1016/j.parkreldis.2018.04.003. [Epub ahead of print] No abstract available.

PMID:
29636215
4.

Long-term safety and efficacy of levodopa-carbidopa intestinal gel in advanced Parkinson's disease.

Fernandez HH, Boyd JT, Fung VSC, Lew MF, Rodriguez RL, Slevin JT, Standaert DG, Zadikoff C, Vanagunas AD, Chatamra K, Eaton S, Facheris MF, Hall C, Robieson WZ, Benesh J, Espay AJ.

Mov Disord. 2018 Mar 23. doi: 10.1002/mds.27338. [Epub ahead of print]

PMID:
29570853
5.

Functional neurological disorders in Parkinson disease.

Wissel BD, Dwivedi AK, Merola A, Chin D, Jacob C, Duker AP, Vaughan JE, Lovera L, LaFaver K, Levy A, Lang AE, Morgante F, Nirenberg MJ, Stephen C, Sharma N, Romagnolo A, Lopiano L, Balint B, Yu XX, Bhatia KP, Espay AJ.

J Neurol Neurosurg Psychiatry. 2018 Mar 16. pii: jnnp-2017-317378. doi: 10.1136/jnnp-2017-317378. [Epub ahead of print]

PMID:
29549192
6.

Congress of Neurological Surgeons Systematic Review and Evidence-Based Guideline on Subthalamic Nucleus and Globus Pallidus Internus Deep Brain Stimulation for the Treatment of Patients With Parkinson's Disease: Executive Summary.

Rughani A, Schwalb JM, Sidiropoulos C, Pilitsis J, Ramirez-Zamora A, Sweet JA, Mittal S, Espay AJ, Martinez JG, Abosch A, Eskandar E, Gross R, Alterman R, Hamani C.

Neurosurgery. 2018 Mar 12. doi: 10.1093/neuros/nyy037. [Epub ahead of print]

PMID:
29538685
7.

Minimal clinically important change in the Toronto Western Spasmodic Torticollis Rating Scale.

Espay AJ, Trosch R, Suarez G, Johnson J, Marchese D, Comella C.

Parkinsonism Relat Disord. 2018 Mar 7. pii: S1353-8020(18)30116-0. doi: 10.1016/j.parkreldis.2018.03.002. [Epub ahead of print]

PMID:
29530726
8.

Cognitive fluctuations in Parkinson's disease dementia: blood pressure lability as an underlying mechanism.

Riley DE, Espay AJ.

J Clin Mov Disord. 2018 Feb 13;5:1. doi: 10.1186/s40734-018-0068-4. eCollection 2018.

9.

Clinical Reasoning: Importance of clinical phenomenology in the era of genetic testing.

Basu MR, Espay AJ, Wakefield EG, Wu SW.

Neurology. 2018 Feb 6;90(6):e534-e537. doi: 10.1212/WNL.0000000000004930. No abstract available.

PMID:
29438030
10.

Future of Neurologic Examination in Clinical Practice.

Marsili L, Espay AJ, Merola A.

JAMA Neurol. 2018 Mar 1;75(3):383. doi: 10.1001/jamaneurol.2017.4998. No abstract available.

PMID:
29435564
11.

Autonomic dysfunction in Parkinson's disease: A prospective cohort study.

Merola A, Romagnolo A, Rosso M, Suri R, Berndt Z, Maule S, Lopiano L, Espay AJ.

Mov Disord. 2018 Mar;33(3):391-397. doi: 10.1002/mds.27268. Epub 2017 Dec 26.

PMID:
29278286
12.

What is "essential" about essential tremor? A diagnostic placeholder.

Fasano A, Lang AE, Espay AJ.

Mov Disord. 2018 Jan;33(1):58-61. doi: 10.1002/mds.27288. Epub 2017 Dec 22. No abstract available.

PMID:
29272067
13.

Orthostatic hypotension in Parkinson disease: Impact on health care utilization.

Merola A, Sawyer RP, Artusi CA, Suri R, Berndt Z, Lopez-Castellanos JR, Vaughan J, Vizcarra JA, Romagnolo A, Espay AJ.

Parkinsonism Relat Disord. 2018 Feb;47:45-49. doi: 10.1016/j.parkreldis.2017.11.344. Epub 2017 Nov 28.

PMID:
29195729
14.

Is there even such a thing as "idiopathic normal pressure hydrocephalus"?

Espay AJ, Lang AE.

Ann Neurol. 2017 Dec;82(6):1032. doi: 10.1002/ana.25097. Epub 2017 Dec 4. No abstract available.

PMID:
29136297
15.

Dysfunction in emotion processing underlies functional (psychogenic) dystonia.

Espay AJ, Maloney T, Vannest J, Norris MM, Eliassen JC, Neefus E, Allendorfer JB, Chen R, Szaflarski JP.

Mov Disord. 2018 Jan;33(1):136-145. doi: 10.1002/mds.27217. Epub 2017 Nov 10.

PMID:
29124784
16.

Perioral and tongue fasciculations in Kennedy's disease.

Pedroso JL, Vale TC, Barsottini OG, Oliveira ASB, Espay AJ.

Neurol Sci. 2018 Apr;39(4):777-779. doi: 10.1007/s10072-017-3170-8. Epub 2017 Nov 4.

PMID:
29103179
17.

Impaired emotion processing in functional (psychogenic) tremor: A functional magnetic resonance imaging study.

Espay AJ, Maloney T, Vannest J, Norris MM, Eliassen JC, Neefus E, Allendorfer JB, Lang AE, Szaflarski JP.

Neuroimage Clin. 2017 Oct 18;17:179-187. doi: 10.1016/j.nicl.2017.10.020. eCollection 2018.

18.

Levodopa and Parkinson Disease-Myths Revisited-Reply.

Espay AJ, Lang AE.

JAMA Neurol. 2017 Oct 1;74(10):1270-1271. doi: 10.1001/jamaneurol.2017.2563. No abstract available.

PMID:
28973085
19.

Teaching Video NeuroImages: Spastic ataxia syndrome: The Friedreich-like phenotype of ARSACS.

Saffie P, Kauffman MA, Fernandez JM, Acosta I, Espay AJ, de la Cerda A.

Neurology. 2017 Oct 3;89(14):e178-e179. doi: 10.1212/WNL.0000000000004556. No abstract available.

PMID:
28972115
20.

App-Based Bradykinesia Tasks for Clinic and Home Assessment in Parkinson's Disease: Reliability and Responsiveness.

Heldman DA, Urrea-Mendoza E, Lovera LC, Schmerler DA, Garcia X, Mohammad ME, McFarlane MCU, Giuffrida JP, Espay AJ, Fernandez HH.

J Parkinsons Dis. 2017;7(4):741-747. doi: 10.3233/JPD-171159.

PMID:
28922169
21.

Deconstructing normal pressure hydrocephalus: Ventriculomegaly as early sign of neurodegeneration.

Espay AJ, Da Prat GA, Dwivedi AK, Rodriguez-Porcel F, Vaughan JE, Rosso M, Devoto JL, Duker AP, Masellis M, Smith CD, Mandybur GT, Merola A, Lang AE.

Ann Neurol. 2017 Oct;82(4):503-513. doi: 10.1002/ana.25046. Epub 2017 Oct 4. Review.

PMID:
28892572
22.

Treatable inherited rare movement disorders.

Jinnah HA, Albanese A, Bhatia KP, Cardoso F, Da Prat G, de Koning TJ, Espay AJ, Fung V, Garcia-Ruiz PJ, Gershanik O, Jankovic J, Kaji R, Kotschet K, Marras C, Miyasaki JM, Morgante F, Munchau A, Pal PK, Rodriguez Oroz MC, Rodríguez-Violante M, Schöls L, Stamelou M, Tijssen M, Uribe Roca C, de la Cerda A, Gatto EM; International Parkinson's Disease Movement Disorders Society Task Force on Rare Movement Disorders.

Mov Disord. 2018 Jan;33(1):21-35. doi: 10.1002/mds.27140. Epub 2017 Sep 1. Review.

PMID:
28861905
23.

Teaching Video NeuroImages: The underrecognized diphasic dyskinesia of Parkinson disease.

Verhagen Metman L, Espay AJ.

Neurology. 2017 Aug 15;89(7):e83-e84. doi: 10.1212/WNL.0000000000004238. No abstract available.

PMID:
28808177
24.

The Parkinson Care Advocate: Integrating Care Delivery.

Sokol LL, Shapiro D, Young MJ, Wise AH, Hadelsberg UP, Kaufman Y, Espay AJ, Merola A.

Front Neurol. 2017 Jul 27;8:364. doi: 10.3389/fneur.2017.00364. eCollection 2017. No abstract available.

25.

Integration of technology-based outcome measures in clinical trials of Parkinson and other neurodegenerative diseases.

Artusi CA, Mishra M, Latimer P, Vizcarra JA, Lopiano L, Maetzler W, Merola A, Espay AJ.

Parkinsonism Relat Disord. 2018 Jan;46 Suppl 1:S53-S56. doi: 10.1016/j.parkreldis.2017.07.022. Epub 2017 Jul 26.

PMID:
28760593
26.

Biometric Digital Health Technology for Measuring Motor Function in Parkinson's Disease: Results from a Feasibility and Patient Satisfaction Study.

Mitsi G, Mendoza EU, Wissel BD, Barbopoulou E, Dwivedi AK, Tsoulos I, Stavrakoudis A, Espay AJ, Papapetropoulos S.

Front Neurol. 2017 Jun 13;8:273. doi: 10.3389/fneur.2017.00273. eCollection 2017.

27.

The Emerging Role of Pimavanserin in the Management of Parkinson's Disease Psychosis.

Hermanowicz N, Alva G, Pagan F, Espay AJ, Patel A, Madrid KC, Kremens D, Kenney J, Arquette S, Tereso G, Lopes M, Farnum C.

J Manag Care Spec Pharm. 2017 Jun;23(6-b Suppl):S2-S8. doi: 10.18553/jmcp.2017.23.6-b.s2. Review.

28.

Thalamic deep brain stimulation for orthostatic tremor: A multicenter international registry.

Merola A, Fasano A, Hassan A, Ostrem JL, Contarino MF, Lyons M, Krauss JK, Wolf ME, Klassen BT, van Rootselaar AF, Regidor I, Duker AP, Ondo W, Guridi J, Volkmann J, Wagle Shukla A, Mandybur GT, Okun MS, Witt K, Starr PA, Deuschl G, Espay AJ.

Mov Disord. 2017 Aug;32(8):1240-1244. doi: 10.1002/mds.27082. Epub 2017 Jun 20.

PMID:
28631862
29.

Peripheral neuropathy as marker of severe Parkinson's disease phenotype.

Merola A, Rosso M, Romagnolo A, Comi C, Fasano A, Zibetti M, Lopez-Castellanos JR, Cocito D, Lopiano L, Espay AJ.

Mov Disord. 2017 Aug;32(8):1256-1258. doi: 10.1002/mds.27025. Epub 2017 May 8. No abstract available.

PMID:
28582598
30.

Parkinson disease in Gaucher disease.

Rodriguez-Porcel F, Espay AJ, Carecchio M.

J Clin Mov Disord. 2017 May 23;4:7. doi: 10.1186/s40734-017-0054-2. eCollection 2017.

31.

Large-scale exploratory genetic analysis of cognitive impairment in Parkinson's disease.

Mata IF, Johnson CO, Leverenz JB, Weintraub D, Trojanowski JQ, Van Deerlin VM, Ritz B, Rausch R, Factor SA, Wood-Siverio C, Quinn JF, Chung KA, Peterson-Hiller AL, Espay AJ, Revilla FJ, Devoto J, Yearout D, Hu SC, Cholerton BA, Montine TJ, Edwards KL, Zabetian CP.

Neurobiol Aging. 2017 Aug;56:211.e1-211.e7. doi: 10.1016/j.neurobiolaging.2017.04.009. Epub 2017 Apr 20.

PMID:
28526295
32.

Multiple modality biomarker prediction of cognitive impairment in prospectively followed de novo Parkinson disease.

Caspell-Garcia C, Simuni T, Tosun-Turgut D, Wu IW, Zhang Y, Nalls M, Singleton A, Shaw LA, Kang JH, Trojanowski JQ, Siderowf A, Coffey C, Lasch S, Aarsland D, Burn D, Chahine LM, Espay AJ, Foster ED, Hawkins KA, Litvan I, Richard I, Weintraub D; Parkinson’s Progression Markers Initiative (PPMI).

PLoS One. 2017 May 17;12(5):e0175674. doi: 10.1371/journal.pone.0175674. eCollection 2017.

33.

Diagnosis and Treatment of Functional (Psychogenic) Parkinsonism.

LaFaver K, Espay AJ.

Semin Neurol. 2017 Apr;37(2):228-232. doi: 10.1055/s-0037-1601487. Epub 2017 May 16.

PMID:
28511263
34.

Parkinson Disease: An Evolutionary Perspective.

Garcia-Ruiz PJ, Espay AJ.

Front Neurol. 2017 May 1;8:157. doi: 10.3389/fneur.2017.00157. eCollection 2017.

35.

Common Myths in the Use of Levodopa in Parkinson Disease: When Clinical Trials Misinform Clinical Practice.

Espay AJ, Lang AE.

JAMA Neurol. 2017 Jun 1;74(6):633-634. doi: 10.1001/jamaneurol.2017.0348. No abstract available.

PMID:
28459962
36.

Psychiatric associations of adult-onset focal dystonia phenotypes.

Berman BD, Junker J, Shelton E, Sillau SH, Jinnah HA, Perlmutter JS, Espay AJ, Jankovic J, Vidailhet M, Bonnet C, Ondo W, Malaty IA, Rodríguez R, McDonald WM, Marsh L, Zurowski M, Bäumer T, Brüggemann N.

J Neurol Neurosurg Psychiatry. 2017 Jul;88(7):595-602. doi: 10.1136/jnnp-2016-315461. Epub 2017 Apr 24.

37.

Multicenter observational study of abobotulinumtoxinA neurotoxin in cervical dystonia: The ANCHOR-CD registry.

Trosch RM, Espay AJ, Truong D, Gil R, Singer C, LeWitt PA, Lew MF, Tagliati M, Adler CH, Chen JJ, Marchese D, Comella CL.

J Neurol Sci. 2017 May 15;376:84-90. doi: 10.1016/j.jns.2017.02.042. Epub 2017 Feb 21.

38.

Diagnosing the frontal variant of Alzheimer's disease: a clinician's yellow brick road.

Sawyer RP, Rodriguez-Porcel F, Hagen M, Shatz R, Espay AJ.

J Clin Mov Disord. 2017 Mar 2;4:2. doi: 10.1186/s40734-017-0052-4. eCollection 2017. Review.

39.

Prevalence and burden of dysautonomia in advanced Parkinson's disease.

Merola A, Romagnolo A, Comi C, Rosso M, Artusi CA, Zibetti M, Lanotte M, Duker AP, Maule S, Lopiano L, Espay AJ.

Mov Disord. 2017 May;32(5):796-797. doi: 10.1002/mds.26970. Epub 2017 Mar 3. No abstract available.

PMID:
28256092
40.

Optimizing extended-release carbidopa/levodopa in Parkinson disease: Consensus on conversion from standard therapy.

Espay AJ, Pagan FL, Walter BL, Morgan JC, Elmer LW, Waters CH, Agarwal P, Dhall R, Ondo WG, Klos KJ, Silver DE.

Neurol Clin Pract. 2017 Feb;7(1):86-93. doi: 10.1212/CPJ.0000000000000316. Review.

41.

Gaps and controversies in movement disorders: Introduction to the series.

Erro R, Espay AJ.

Mov Disord. 2017 Mar;32(3):309. doi: 10.1002/mds.26965. Epub 2017 Feb 24. No abstract available.

PMID:
28233933
42.

Biomarker-driven phenotyping in Parkinson's disease: A translational missing link in disease-modifying clinical trials.

Espay AJ, Schwarzschild MA, Tanner CM, Fernandez HH, Simon DK, Leverenz JB, Merola A, Chen-Plotkin A, Brundin P, Kauffman MA, Erro R, Kieburtz K, Woo D, Macklin EA, Standaert DG, Lang AE.

Mov Disord. 2017 Mar;32(3):319-324. doi: 10.1002/mds.26913. Epub 2017 Feb 24. Review.

43.

Subthalamic or red nucleus? A puzzling question arising during intraoperative recording for DBS.

Merola A, Mandybur G, Biddell K, Tareen TK, Wilson-Perez H, Espay AJ, Duker AP.

Clin Neurophysiol. 2017 Apr;128(4):558-560. doi: 10.1016/j.clinph.2017.01.011. Epub 2017 Jan 28. No abstract available.

PMID:
28231473
44.

Thalamic deep brain stimulation and gait in orthostatic tremor.

Merola A, Duker AP, Mandybur G, Tareen TK, Tuazon J, Espay AJ, Fasano A.

Mov Disord. 2017 Jun;32(6):937-938. doi: 10.1002/mds.26958. Epub 2017 Feb 20. No abstract available.

PMID:
28218418
45.

Pure autonomic failure versus prodromal dysautonomia in Parkinson’s disease: Insights from the bedside.

Merola A, Espay AJ, Zibetti M, Romagnolo A, Rosso M, Maule S, Lopiano L.

Mov Disord Clin Pract. 2017 Jan;4(1):141-144. doi: 10.1002/mdc3.12360. Epub 2016 May 19. No abstract available.

46.

Essential pitfalls in "essential" tremor.

Espay AJ, Lang AE, Erro R, Merola A, Fasano A, Berardelli A, Bhatia KP.

Mov Disord. 2017 Mar;32(3):325-331. doi: 10.1002/mds.26919. Epub 2017 Jan 24. Review.

47.

Precision medicine for disease modification in Parkinson disease.

Espay AJ, Brundin P, Lang AE.

Nat Rev Neurol. 2017 Feb;13(2):119-126. doi: 10.1038/nrneurol.2016.196. Epub 2017 Jan 20. Review. No abstract available.

PMID:
28106064
48.

The epileptic and nonepileptic spectrum of paroxysmal dyskinesias: Channelopathies, synaptopathies, and transportopathies.

Erro R, Bhatia KP, Espay AJ, Striano P.

Mov Disord. 2017 Mar;32(3):310-318. doi: 10.1002/mds.26901. Epub 2017 Jan 16. Review.

49.

Common variant rs356182 near SNCA defines a Parkinson's disease endophenotype.

Cooper CA, Jain N, Gallagher MD, Weintraub D, Xie SX, Berlyand Y, Espay AJ, Quinn J, Edwards KL, Montine T, Van Deerlin VM, Trojanowski J, Zabetian CP, Chen-Plotkin AS.

Ann Clin Transl Neurol. 2016 Nov 25;4(1):15-25. doi: 10.1002/acn3.371. eCollection 2017 Jan.

50.

Rapidly progressive primary progressive aphasia and parkinsonism with novel GRN mutation.

Galimberti D, Cioffi SM, Fenoglio C, Serpente M, Oblak AL, Rodriguez-Porcel F, Oldoni E, Hagen MC, Arcaro M, Scarpini E, Ghetti B, Espay AJ.

Mov Disord. 2017 Mar;32(3):476-478. doi: 10.1002/mds.26872. Epub 2016 Nov 15. No abstract available.

PMID:
27859661

Supplemental Content

Loading ...
Support Center